Accessibility Menu
 
Cbd Life Sciences logo

Cbd Life Sciences

(OTC) CBDL

Current Price$0.00
Market Cap$1.51M
Since IPO (2012)-100%
5 Year-100%
1 Year-34%
1 Month+33%

Cbd Life Sciences Financials at a Glance

Market Cap

$1.51M

Revenue (TTM)

$71.05K

Net Income (TTM)

$643.33K

EPS (TTM)

$-0.00

P/E Ratio

-0.66

Dividend

$0.00

Beta (Volatility)

-77.29 (Low)

Price

$0.00

Volume

94,780,534

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

CBDL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cbd Life Sciences

Industry

Pharmaceuticals

CEO

Lisa Nelson

Headquarters

Scottsdale, AZ 85259, US

CBDL Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-1%

Net Income Margin

-14%

Return on Equity

-191%

Return on Capital

-8%

Return on Assets

-1%

Earnings Yield

-1.52%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.51M

Shares Outstanding

5.70B

Volume

94.78M

Avg. Volume

22.43M

Financials (TTM)

Gross Profit

$41.49K

Operating Income

$101.70K

EBITDA

$101.70K

Operating Cash Flow

$139.15K

Capital Expenditure

$0.00

Free Cash Flow

$139.15K

Cash & ST Invst.

$331.60K

Total Debt

$0.00

Cbd Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$28.24K

-28.0%

Gross Profit

$11.81K

-25.0%

Gross Margin

41.82%

N/A

Market Cap

$1.51M

N/A

Market Cap/Employee

$503.23K

N/A

Employees

3

N/A

Net Income

$31.55K

+146.7%

EBITDA

$26.80K

+45.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$331.60K

+1791.3%

Accounts Receivable

$215.69K

+5.5%

Inventory

$35.08K

+240.6%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-0.75%

N/A

Return on Invested Capital

-8.40%

N/A

Free Cash Flow

$46.01K

+3968.1%

Operating Cash Flow

$46.01K

+3967.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GPFTGrapefruit USA, Inc.
$0.00+9.09%
AOXGAoxing Pharmaceutical Company, Inc.
$0.01+23.81%
HPMMHemp Naturals, Inc.
$0.00+0.00%
LRSVLink Reservations Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About CBDL

What is the current price of Cbd Life Sciences?

Cbd Life Sciences is trading at $0.00 per share.

What is the 52-week range for Cbd Life Sciences?

Over the past 52 weeks, Cbd Life Sciences has traded between $0.00 and $0.00.

How much debt does Cbd Life Sciences have?

As of the most recent reporting period, Cbd Life Sciences reported total debt of N/A.

How much cash does Cbd Life Sciences have on hand?

Cbd Life Sciences reported $331,598 in cash and cash equivalents in its most recent financial results.

What is Cbd Life Sciences’s dividend yield?

Cbd Life Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.